WYETH-AYERST'S LODINE APPROVED FOR TREATMENT OF OSTEOARTHRITIS AND PAIN RELIEF; TWICE-DAILY ANTIARTHRITIC WILL ENTER CROWDED NSAID MARKET THIS SPRING

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".